Evidence map›Paper›PMID 41972643›Full record

ReviewNanomaterials (Basel, Switzerland)2026

Polyoxometalates (POMs) Memristors/Neuromorphic Devices: From Structure Engineering to Material and Function Integration.

Jufang Hu, Shengzhang Xu, Yanfang Meng

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jufang HuKey Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Physics and Optoelectronic Engineering, Shenzhen University, No. 3688, Nanhai Avenue, Nanshan District, Shenzhen 518060, China.ORCID 0000-0002-2105-1718
Shengzhang XuNational Pipeline Eastern Crude Oil Storage and Transportation Co., Ltd., No. 1, Beijing Road, Quanshan District, Xuzhou 221116, China.
Yanfang MengDepartment of Mechanical and Electronic Engineering, School of Mechanical Engineering, Jiangsu University, No. 301, Xuefu Road, Jingkou District, Zhenjiang 212013, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The advancement of artificial intelligence and information technologies has presented higher demands on neuromorphic computing information devices, entailing the emergence of next-generation devices. Polyoxometalates (POMs) are emerging as promising molecular nanomaterials for next-generation neuromorphic computing, providing distinct advantages over conventional metal oxides. In contrast to bulk oxides that suffer from stochastic filament formation and device-to-device variability, POMs possess atomically precise structures with discrete, multi-electron redox states that enable highly reproducible and deterministic resistive switching. Their molecular nature allows for stable, multi-level data representation through stepwise reduction in metal centers (e.g., V, W, Mo) and the emulation of essential synaptic plasticity functions. Furthermore, the exceptional structural and chemical tunability of POMs favors covalent or supramolecular functionalization, enabling precise engineering of the POM-electrode interface and controlled self-assembly on surfaces. This molecular precision not only addresses the scalability challenges of traditional memristors but also unlocks unique functionalities, such as multimodal switching coupled with visible chromic response for state visualization. Taking the advantages of intermolecular crosstalk and countercation dynamics, POM-based networks offer a pathway toward constructing three-dimensional neuronal architectures, effectively connecting molecular redox chemistry to advanced high-density neuromorphic computing paradigms.

Indexed as

electronic featuresmemristorneuromorphicpolyoxometalate (POM)

Identifiers

PMID41972643
PMCPMC13074768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.